Peterson Financial Group Inc. acquired a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 368 shares of the financial services provider’s stock, valued at approximately $30,000.
A number of other large investors have also added to or reduced their stakes in MET. MeadowBrook Investment Advisors LLC increased its position in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares during the period. Carmichael Hill & Associates Inc. increased its holdings in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC raised its position in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares during the last quarter. Fortitude Family Office LLC grew its position in shares of MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares during the last quarter. Finally, Coastline Trust Co acquired a new stake in shares of MetLife in the third quarter valued at about $35,000. Institutional investors own 89.81% of the company’s stock.
MetLife Price Performance
Shares of NYSE MET opened at $83.33 on Friday. The stock has a market cap of $57.70 billion, a price-to-earnings ratio of 16.80, a PEG ratio of 0.76 and a beta of 1.05. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a fifty-two week low of $61.61 and a fifty-two week high of $86.94. The firm’s 50-day simple moving average is $81.60 and its 200 day simple moving average is $75.59.
MetLife Announces Dividend
Wall Street Analysts Forecast Growth
MET has been the topic of a number of recent analyst reports. TD Cowen assumed coverage on MetLife in a research note on Wednesday, October 9th. They issued a “buy” rating and a $97.00 price objective on the stock. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. Wells Fargo & Company increased their price objective on shares of MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Barclays dropped their target price on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. Finally, Jefferies Financial Group increased their price target on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. Fourteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $88.46.
Check Out Our Latest Analysis on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- P/E Ratio Calculation: How to Assess Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Ride Out The Recession With These Dividend Kings
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What is the Hang Seng index?
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.